Loading…
LOANS for Biomedical Research Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
60pct
3d open
vs 10,564 other HR bills in the 118th — cohort avg 68d
Long-term Opportunities for Advancing New Studies for Biomedical Research Act or the LOANS for Biomedical Research Act This bill requires the Department of the Treasury to establish the BioBonds Program to support loans for clinical trials for eligible drugs and medical devices for unmet medical needs. Under the program, fiscal agents purchase loans (up to $25 million per recipient) and issue collateralized bonds that are sold to investors and that are guaranteed by Treasury. An eligible borrower under this program is one conducting (or seeking to conduct) research related to a drug or device that is (1) intended to meet an unmet medical need; and (2) under investigation in certain types of controlled clinical trials, including a trial to investigate the safety and effectiveness of the drug or device. The Government Accountability Office (GAO) and Treasury must report on the program; GAO must also study whether similar programs should be established for other biomedical research projects.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2026 · third_quarter · Health Issues
Health care and innovation issues H.R. 7539 LOANS for Biomedical Research Act Cameron's Law
Client expense: Not reported · Firm income: $30,000
Referred to the Subcommittee on Health.
Referred to the House Committee on Energy and Commerce.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Small Business Administration (SBA)
2026 · second_quarter · Health Issues
Health care and innovation issues H.R. 7539 LOANS for Biomedical Research Act Cameron's Law
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Small Business Administration (SBA)
2026 · first_quarter · Health Issues
Health care and innovation issues H.R. 7539 LOANS for Biomedical Research Act Give Kids a Chance Act Cameron's Law
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Small Business Administration (SBA)
2025 · fourth_quarter · Health Issues
Health care and innovation issues H.R.7539, LOANS for Biomedical Research Act Give Kids a Chance Act ARPA-H
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Small Business Administration (SBA)
2025 · third_quarter · Health Issues
Health care and innovation issues H.R.7539, LOANS for Biomedical Research Act Give Kids a Chance Act
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Small Business Administration (SBA)
2025 · second_quarter · Health Issues
Health care and innovation issues H.R.7539, LOANS for Biomedical Research Act Give Kids a Chance Act
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2025 · first_quarter · Health Issues
Health care and innovation issues H.R.7539, LOANS for Biomedical Research Act
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2024 · third_quarter · Health Issues
support for the Safe Step Act H.R. 2630 and S. 652, support for H.R. 8400 Early Detection of Vision Impairments for Children Act supporting children's vision and eye health, S. 2323 the Access to Genetic Counselor Services Act, Long-term Opportunities for Advancing New Studies (LOANS) for Biomedical Research Act H.R. 7539
Client expense: $28,750 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Health Issues
Health care and innovation issues H.R.7539, LOANS for Biomedical Research Act
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2024 · third_quarter · Health Issues
Health care and innovation issues H.R.7539, LOANS for Biomedical Research Act
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Health Issues
support for the Safe Step Act H.R. 2630 and S. 652, support for H.R. 8400 Early Detection of Vision Impairments for Children Act supporting children's vision and eye health, S. 2323 the Access to Genetic Counselor Services Act, Long-term Opportunities for Advancing New Studies (LOANS) for Biomedical Research Act H.R. 7539
Client expense: $35,870 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Health Issues
Health care and innovation issues H.R.7539, LOANS for Biomedical Research Act
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · first_quarter · Health Issues
support for the safe step act H.R. 2163, unnumbered bill supporting children's vision and eye health, S. 2323 the Access to Genetic Counselor Services Act, Long-term Opportunities for Advancing New Studies (LOANS) for Biomedical Research Act H.R. 7539
Client expense: $24,640 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
| Democratic |
| HI |
| Josh Gottheimer | Democratic | NJ |
| Mike Levin | Democratic | CA |
| Pete Sessions | Republican | TX |
| Sanford D. Bishop, Jr. | Democratic | GA |